<sec><title>INTRODUCTION</title>: Antimicrobial resistance is an increasing threat in hospitalized patients, and inappropriate empirical antimicrobial therapy is known to adversely affect outcomes in ventilator-associated pneumonia (VAP). The aim of this study was to evaluate antim...

Full description

Bibliographic Details
Main Authors: Michel Rodrigues Moreira, Munick Paula Guimarães, Aurélia Aparecida de Araújo Rodrigues, Paulo Pinto Gontijo Filho
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2013-01-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822013000100039
id doaj-c800a2604e3f492aa453905eb04bc88b
record_format Article
spelling doaj-c800a2604e3f492aa453905eb04bc88b2020-11-24T23:43:16ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical0037-86821678-98492013-01-014613944Michel Rodrigues MoreiraMunick Paula GuimarãesAurélia Aparecida de Araújo RodriguesPaulo Pinto Gontijo Filho<sec><title>INTRODUCTION</title>: Antimicrobial resistance is an increasing threat in hospitalized patients, and inappropriate empirical antimicrobial therapy is known to adversely affect outcomes in ventilator-associated pneumonia (VAP). The aim of this study was to evaluate antimicrobial usage, incidence, etiology, and antimicrobial resistance trends for prominent nosocomial pathogens causing ventilator-associated pneumonia in a clinical-surgical intensive care unit (ICU). </sec><sec><title>METHODS</title>: Gram-negative bacilli and Staphylococcus aureus causing VAP, as well as their antimicrobial resistance patterns and data on consumption (defined daily dose [DDD] per 1,000 patient days) of glycopeptides, extended-spectrum cephalosporins, and carbapenems in the unit were evaluated in two different periods (A and B). </sec><sec><title>RESULTS:</title> Antimicrobial use was high, mainly of broad-spectrum cephalosporins, with a significant increase in the consumption of glycopeptides (p < 0.0001) and carbapenems (p < 0.007) in period B. For Acinetobacter baumannii and members of the Enterobacteriaceae family, 5.27- and 3.06-fold increases in VAPs, respectively, were noted, and a significant increase in resistance rates was found for imipenem-resistant A. baumannii (p = 0.003) and third-generation cephalosporins-resistant Enterobacteriaceae (p = 0.01) isolates in this same period. </sec><sec><title>CONCLUSIONS:</title> Our results suggest that there is a link between antibiotics usage at institutional levels and resistant bacteria. The use of carbapenems was related to the high rate of resistance in A. baumannii and therefore a high consumption of imipenem/meropenem could play a major role in selective pressure exerted by antibiotics in A. baumannii strains.</sec>http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822013000100039Antibiotic consumptionIntensive care unitVentilator-associated pneumoniaAntimicrobial resistance
collection DOAJ
language English
format Article
sources DOAJ
author Michel Rodrigues Moreira
Munick Paula Guimarães
Aurélia Aparecida de Araújo Rodrigues
Paulo Pinto Gontijo Filho
spellingShingle Michel Rodrigues Moreira
Munick Paula Guimarães
Aurélia Aparecida de Araújo Rodrigues
Paulo Pinto Gontijo Filho
Revista da Sociedade Brasileira de Medicina Tropical
Antibiotic consumption
Intensive care unit
Ventilator-associated pneumonia
Antimicrobial resistance
author_facet Michel Rodrigues Moreira
Munick Paula Guimarães
Aurélia Aparecida de Araújo Rodrigues
Paulo Pinto Gontijo Filho
author_sort Michel Rodrigues Moreira
publisher Sociedade Brasileira de Medicina Tropical (SBMT)
series Revista da Sociedade Brasileira de Medicina Tropical
issn 0037-8682
1678-9849
publishDate 2013-01-01
description <sec><title>INTRODUCTION</title>: Antimicrobial resistance is an increasing threat in hospitalized patients, and inappropriate empirical antimicrobial therapy is known to adversely affect outcomes in ventilator-associated pneumonia (VAP). The aim of this study was to evaluate antimicrobial usage, incidence, etiology, and antimicrobial resistance trends for prominent nosocomial pathogens causing ventilator-associated pneumonia in a clinical-surgical intensive care unit (ICU). </sec><sec><title>METHODS</title>: Gram-negative bacilli and Staphylococcus aureus causing VAP, as well as their antimicrobial resistance patterns and data on consumption (defined daily dose [DDD] per 1,000 patient days) of glycopeptides, extended-spectrum cephalosporins, and carbapenems in the unit were evaluated in two different periods (A and B). </sec><sec><title>RESULTS:</title> Antimicrobial use was high, mainly of broad-spectrum cephalosporins, with a significant increase in the consumption of glycopeptides (p < 0.0001) and carbapenems (p < 0.007) in period B. For Acinetobacter baumannii and members of the Enterobacteriaceae family, 5.27- and 3.06-fold increases in VAPs, respectively, were noted, and a significant increase in resistance rates was found for imipenem-resistant A. baumannii (p = 0.003) and third-generation cephalosporins-resistant Enterobacteriaceae (p = 0.01) isolates in this same period. </sec><sec><title>CONCLUSIONS:</title> Our results suggest that there is a link between antibiotics usage at institutional levels and resistant bacteria. The use of carbapenems was related to the high rate of resistance in A. baumannii and therefore a high consumption of imipenem/meropenem could play a major role in selective pressure exerted by antibiotics in A. baumannii strains.</sec>
topic Antibiotic consumption
Intensive care unit
Ventilator-associated pneumonia
Antimicrobial resistance
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822013000100039
_version_ 1725502336226295808